Ding Pengsheng相关文献与解析，生知库 | 链接生命科学的每一步

Ding, Pengsheng; Shi, Lan; Xu, Xuexue; Lu, Bing; Liu, Gan; Wang, Yangyan; Nie, Zhengchao; Wang, Xiaofang; Chang, Wenjiao; Dai, Yuanyuan; Ma, Xiaoling; Zhang, Shanshan

肿瘤

BCL6

肿瘤免疫

ARID1A deficiency promotes malignant proliferation of hepatocellular carcinoma by activating HDAC7/ENO1 signaling pathway.

ARID1A 缺陷通过激活 HDAC7/ENO1 信号通路促进肝细胞癌的恶性增殖

期刊:Hepatology Communications

影响因子:4.6

doi:10.1097/HC9.0000000000000738

Zhang Shanshan, Wu Gang, Shi Lan, Ding Pengsheng, Liu Gan, Chang Wenjiao, Dai Yuanyuan, Han Xinghua, Ma Xiaoling

Toxin protein LukS-PV targeting complement receptor C5aR1 inhibits cell proliferation in hepatocellular carcinoma via the HDAC7-Wnt/Î²-catenin axis.

毒素蛋白 LukS-PV 靶向补体受体 C5aR1，通过 HDAC7-Wnt/β-catenin 轴抑制肝细胞癌细胞增殖

期刊:Journal of Biological Chemistry

影响因子:3.9

doi:10.1016/j.jbc.2024.108148

Shi Lan, Zhang Shanshan, Liu Gan, Nie Zhengchao, Ding Pengsheng, Chang Wenjiao, Dai Yuanyuan, Ma Xiaoling

LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression

LukS-PV通过下调HDAC6表达抑制肝细胞癌细胞迁移

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-022-09680-4

Xu, Xuexue; Ding, Pengsheng; Shi, Lan; Wu, Gang; Ma, Xiaoling

Clinicopathological features and prognostic significance of C5aR in human solid tumors: a Meta-analysis

C5aR在人类实体瘤中的临床病理特征及预后意义：一项荟萃分析

期刊:BMC Cancer

影响因子:3.4

doi:10.1186/s12885-021-08883-5

Wang, Ziran; Yu, Wenwei; Qiang, Yawen; Ma, Fan; Ding, Pengsheng; Wang, Yangyan

发表日期：2021

文献求助收藏

Erratum: LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression

更正：LukS-PV通过下调HDAC2表达抑制肝细胞癌进展

期刊:Molecular Therapy-Oncolytics

影响因子:5.3

doi:10.1016/j.omto.2020.10.013

Wang, Ziran; Yu, Wenwei; Qiang, Yawen; Xu, Liangfei; Ma, Fan; Ding, Pengsheng; Shi, Lan; Chang, Wenjiao; Mei, Yide; Ma, Xiaoling

LukS-PV targeting C5aR inhibits EMT in hepatocellular carcinoma via the BCL6/HDAC6/HSPD1 axis

LukS-PV靶向C5aR，通过BCL6/HDAC6/HSPD1轴抑制肝细胞癌中的EMT。

ARID1A deficiency promotes malignant proliferation of hepatocellular carcinoma by activating HDAC7/ENO1 signaling pathway.

ARID1A 缺陷通过激活 HDAC7/ENO1 信号通路促进肝细胞癌的恶性增殖

Toxin protein LukS-PV targeting complement receptor C5aR1 inhibits cell proliferation in hepatocellular carcinoma via the HDAC7-Wnt/Î²-catenin axis.

毒素蛋白 LukS-PV 靶向补体受体 C5aR1，通过 HDAC7-Wnt/β-catenin 轴抑制肝细胞癌细胞增殖

LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression

LukS-PV通过下调HDAC6表达抑制肝细胞癌细胞迁移

Clinicopathological features and prognostic significance of C5aR in human solid tumors: a Meta-analysis

C5aR在人类实体瘤中的临床病理特征及预后意义：一项荟萃分析

Erratum: LukS-PV Inhibits Hepatocellular Carcinoma Progression by Downregulating HDAC2 Expression

更正：LukS-PV通过下调HDAC2表达抑制肝细胞癌进展